Rheopheresis: Difference between revisions
Content deleted Content added
trimmed DM and improved ref |
Burakbahar (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
'''Rheopheresis''' is a process to change the viscosity of blood |
'''Rheopheresis''' is a process to change the viscosity of blood |
||
by filtering blood to remove some components such as [[fibrinogen]], [[von Willebrand factor]] |
by filtering blood to remove some components such as [[fibrinogen]], [[von Willebrand factor]] [[LDL cholesterol]]. |
||
It is experimental treatment for dry [[age-related macular degeneration]] (AMD)<ref>{{cite journal|last1=Leung|first1=E|last2=Landa|first2=G|title=Update on current and future novel therapies for dry age-related macular degeneration.|journal=Expert review of clinical pharmacology|date=September 2013|volume=6|issue=5|pages=565-79|pmid=23971874}}</ref> and acute ischemic stroke <ref>http://stroke.ahajournals.org/cgi/content/abstract/strokeaha;30/4/787 "Extracorporeal Rheopheresis in the Treatment of Acute Ischemic Stroke " 1999</ref> |
It is experimental treatment for dry [[age-related macular degeneration]] (AMD)<ref>{{cite journal|last1=Leung|first1=E|last2=Landa|first2=G|title=Update on current and future novel therapies for dry age-related macular degeneration.|journal=Expert review of clinical pharmacology|date=September 2013|volume=6|issue=5|pages=565-79|pmid=23971874}}</ref> and acute ischemic stroke <ref>http://stroke.ahajournals.org/cgi/content/abstract/strokeaha;30/4/787 "Extracorporeal Rheopheresis in the Treatment of Acute Ischemic Stroke " 1999</ref> |
||
Revision as of 18:10, 31 August 2017
Rheopheresis is a process to change the viscosity of blood by filtering blood to remove some components such as fibrinogen, alpha-2-macroglobulin, von Willebrand factor, LDL cholesterol and immunoglobulin M.[1]
It is experimental treatment for dry age-related macular degeneration (AMD)[2] and acute ischemic stroke [3]
References
- ^ Klingel, Reinhard; Fassbender, Cordula; Fassbender, Thurid; Erdtracht, Bernard; Berrouschot, Jörg (1 October 2000). "Rheopheresis: Rheologic, Functional, and Structural Aspects". Therapeutic Apheresis. 4 (5): 348–357. doi:10.1046/j.1526-0968.2000.004005348.x.
- ^ Leung, E; Landa, G (September 2013). "Update on current and future novel therapies for dry age-related macular degeneration". Expert review of clinical pharmacology. 6 (5): 565–79. PMID 23971874.
- ^ http://stroke.ahajournals.org/cgi/content/abstract/strokeaha;30/4/787 "Extracorporeal Rheopheresis in the Treatment of Acute Ischemic Stroke " 1999